Почетна › Беркитов лимфом › Kolorado › Aurora

Kliničke studije za Беркитов лимфом u gradu Aurora, CO

10 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Aurora i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Тражи се учесникФаза 1

Children's Hospital Colorado, Aurora

Узраст од 0 до 18 · Оба пола · Ажурирано 13. 11. 2026. · NCT06173518

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2

Children's Hospital Colorado, Aurora

Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Тражи се учесникОпсервациона студија

Children's Hospital Colorado, Aurora

Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2

Children's Hospital Colorado, Aurora

365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2

Children's Hospital Colorado, Aurora

366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Тражи се учесникФаза 1/2

Children's Hospital Colorado, Aurora

31 Days – 30 Years · Оба пола · Ажурирано 14. 9. 2026. · NCT04544592

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3

Children's Hospital Colorado, Aurora

365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Тражи се учесникФаза 1

Children's Hospital Colorado, Aurora

3 Months – 30 Years · Оба пола · Ажурирано 28. 11. 2025. · NCT06559189

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Тражи се учесникФаза 2

Children's Hospital Colorado, Aurora

Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Aurora

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.